160 related articles for article (PubMed ID: 33103243)
1. Patients with hepatocellular carcinoma from more rural and lower-income households have more advanced tumor stage at diagnosis and significantly higher mortality.
Wong RJ; Kim D; Ahmed A; Singal AK
Cancer; 2021 Jan; 127(1):45-55. PubMed ID: 33103243
[TBL] [Abstract][Full Text] [Related]
2. Rural-Urban Geographical Disparities in Hepatocellular Carcinoma Incidence Among US Adults, 2004-2017.
Wong RJ; Saab S; Konyn P; Sundaram V; Khalili M
Am J Gastroenterol; 2021 Feb; 116(2):401-406. PubMed ID: 32976121
[TBL] [Abstract][Full Text] [Related]
3. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
[TBL] [Abstract][Full Text] [Related]
4. Presentation, Management, and Outcomes Across the Rural-Urban Continuum for Hepatocellular Carcinoma.
Zhou K; Pickering TA; Gainey CS; Cockburn M; Stern MC; Liu L; Unger JB; El-Khoueiry AB; Terrault NA
JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33442663
[TBL] [Abstract][Full Text] [Related]
5. Older Patients With Hepatocellular Carcinoma Have More Advanced Disease, Lower Rates of Treatment, and Lower Survival.
Yan M; Ha J; Aguilar M; Liu B; Frenette CT; Bhuket T; Wong RJ
J Clin Gastroenterol; 2017 Apr; 51(4):378-383. PubMed ID: 27380460
[TBL] [Abstract][Full Text] [Related]
6. Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment.
Wang J; Ha J; Lopez A; Bhuket T; Liu B; Wong RJ
J Clin Gastroenterol; 2018; 52(5):437-443. PubMed ID: 28723861
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma in patients with chronic kidney disease.
Lee CH; Hsieh SY; Lin JL; Liu MS; Yen TH
World J Gastroenterol; 2013 Apr; 19(16):2466-72. PubMed ID: 23674847
[TBL] [Abstract][Full Text] [Related]
8. Effect of socioeconomic status on hepatocellular carcinoma incidence and stage at diagnosis, a population-based cohort study.
Anyiwe K; Qiao Y; De P; Yoshida EM; Earle CC; Thein HH
Liver Int; 2016 Jun; 36(6):902-10. PubMed ID: 26455359
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.
Fenoglio L; Serraino C; Castagna E; Cardellicchio A; Pomero F; Grosso M; Senore C
World J Gastroenterol; 2013 Jun; 19(21):3207-16. PubMed ID: 23745022
[TBL] [Abstract][Full Text] [Related]
10. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
11. Birth cohort-specific disparities in hepatocellular carcinoma stage at diagnosis, treatment, and long-term survival.
Yan M; Ha J; Aguilar M; Bhuket T; Liu B; Gish RG; Cheung R; Wong RJ
J Hepatol; 2016 Feb; 64(2):326-332. PubMed ID: 26386160
[TBL] [Abstract][Full Text] [Related]
12. Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma.
Rich NE; Murphy CC; Yopp AC; Tiro J; Marrero JA; Singal AG
Aliment Pharmacol Ther; 2020 Aug; 52(4):701-709. PubMed ID: 32598091
[TBL] [Abstract][Full Text] [Related]
13. Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study.
Flores YN; Datta GD; Yang L; Corona E; Devineni D; Glenn BA; Bastani R; May FP
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1193-1199. PubMed ID: 33737301
[TBL] [Abstract][Full Text] [Related]
14. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
El-Serag HB; Davila JA
Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
[TBL] [Abstract][Full Text] [Related]
15. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
[TBL] [Abstract][Full Text] [Related]
16. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
17. Sociodemographic impact on survival in unresectable hepatocellular carcinoma: a survival epidemiology and end results study.
Kokabi N; Xing M; Duszak R; Duszak R; Howard DH; Applegate KE; Camacho JC; Kim HS
Future Oncol; 2016 Jan; 12(2):183-98. PubMed ID: 26690268
[TBL] [Abstract][Full Text] [Related]
18. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
[TBL] [Abstract][Full Text] [Related]
19. Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma.
Wu MT; He SY; Chen SL; Li LF; He ZQ; Zhu YY; He X; Chen H
BMC Cancer; 2019 Jun; 19(1):538. PubMed ID: 31164099
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
